Tempest Therapeutics, Inc. (NASDAQ:TPST – Get Free Report) shares dropped 2.1% during trading on Monday . The stock traded as low as $3.24 and last traded at $3.25. Approximately 230,846 shares traded hands during trading, a decline of 71% from the average daily volume of 787,374 shares. The stock had previously closed at $3.32. Analysts […]
Glancy Prongay & Murray LLP Announces Investigation of Tempest Therapeutics, Inc. (TPST) tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Tempest Therapeutics : Corporate Presentation - June 2024 marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright Reaffirms "Buy" Rating for Tempest Therapeutics (NASDAQ:TPST) tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Tempest Therapeutics' (TPST) "Buy" Rating Reiterated at HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.